KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $224 | -5.5% | 23,250 | -11.6% | 0.01% | +10.0% |
| Q2 2023 | $237 | +5.8% | 26,290 | -7.8% | 0.01% | -9.1% |
| Q1 2023 | $224 | -99.9% | 28,510 | +135.3% | 0.01% | -83.3% |
| Q4 2020 | $230,000 | +28.5% | 12,119 | -14.8% | 0.07% | +15.8% |
| Q3 2020 | $179,000 | +32.6% | 14,219 | +27.8% | 0.06% | +23.9% |
| Q2 2020 | $135,000 | -6.2% | 11,129 | -40.9% | 0.05% | -24.6% |
| Q1 2020 | $144,000 | -42.2% | 18,829 | +34.8% | 0.06% | -17.6% |
| Q4 2019 | $249,000 | -25.2% | 13,969 | -51.4% | 0.07% | -40.3% |
| Q3 2019 | $333,000 | -39.0% | 28,736 | +16.5% | 0.12% | -38.6% |
| Q2 2019 | $546,000 | +14.9% | 24,667 | +48.7% | 0.20% | -25.5% |
| Q1 2019 | $475,000 | +24.3% | 16,591 | -14.2% | 0.27% | +153.3% |
| Q4 2018 | $382,000 | – | 19,341 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |